0.2806
전일 마감가:
$0.2927
열려 있는:
$0.28
하루 거래량:
682.35K
Relative Volume:
1.83
시가총액:
$11.59M
수익:
$7.10M
순이익/손실:
$-39.43M
주가수익비율:
-0.2985
EPS:
-0.94
순현금흐름:
$-46.50M
1주 성능:
-4.91%
1개월 성능:
-21.47%
6개월 성능:
-38.45%
1년 성능:
-66.57%
스프루스 바이오 Stock (SPRB) Company Profile
명칭
Spruce Biosciences Inc
전화
(415) 655-4168
주소
611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO
SPRB을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
SPRB
Spruce Biosciences Inc
|
0.2806 | 11.59M | 7.10M | -39.43M | -46.50M | -0.94 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
스프루스 바이오 Stock (SPRB) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-11 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
2024-12-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2024-03-14 | 다운그레이드 | Guggenheim | Buy → Neutral |
2024-03-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2024-03-14 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
2024-03-14 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
2024-03-14 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2024-02-21 | 개시 | Guggenheim | Buy |
2021-12-17 | 개시 | Oppenheimer | Outperform |
2021-12-10 | 개시 | The Benchmark Company | Speculative Buy |
2021-11-16 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
2021-07-19 | 개시 | H.C. Wainwright | Buy |
2021-04-26 | 재개 | Credit Suisse | Outperform |
2020-11-03 | 개시 | Cowen | Outperform |
2020-11-03 | 개시 | Credit Suisse | Outperform |
2020-11-03 | 개시 | RBC Capital Mkts | Outperform |
2020-11-03 | 개시 | SVB Leerink | Outperform |
모두보기
스프루스 바이오 주식(SPRB)의 최신 뉴스
Layoff Tracker: Relay Will Cut 70 Employees, Affecting Research Budget by 75% - BioSpace
Spruce Biosciences reports delayed annual filing By Investing.com - Investing.com South Africa
Spruce Biosciences reports delayed annual filing - Investing.com
Spruce Biosciences Delays Annual Report Filing - TipRanks
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Spruce Biosciences stock hits 52-week low at $0.32 - Investing.com
In-Depth Analysis Of The Global Congenital Adrenal Hyperplasia Market: Key Drivers, Trends, Growth Opportun... - WhaTech
SPRUCE BIOSCIENCES INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
Invivyd, Inc. (IVVD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Analysts Set Spruce Biosciences, Inc. (NASDAQ:SPRB) PT at $2.38 - Defense World
SPRB Stock Touches 52-Week Low at $0.34 Amid Steep Decline - Investing.com India
Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Spruce Biosciences (SPRB) to Release Quarterly Earnings on Wednesday - Defense World
Harbour Biomed newco HBM Alpha pens $395M hyperplasia drug deal - BioWorld Online
SPRB stock touches 52-week low at $0.34 amid sharp annual decline - Investing.com
Short Interest in Kingsoft Co. Limited (OTCMKTS:KSFTF) Increases By 79.4% - Defense World
Archer-Daniels-Midland Company (NYSE:ADM) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
Traws Pharma, Inc. (NASDAQ:TRAW) Short Interest Update - Defense World
Spruce Biosciences, Inc. (NASDAQ:SPRB) Short Interest Up 81.4% in February - Defense World
SPRB stock touches 52-week low at $0.34 amid sharp annual decline By Investing.com - Investing.com South Africa
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates - MSN
NeoGenomics (NEO) Tops Q4 Earnings Estimates - Yahoo Finance
The Prothena Corporation plc (PRTA) had a good session last reading, didn’t it? - US Post News
Element Solutions Inc (NYSE:ESI) Receives $30.14 Consensus Price Target from Analysts - Defense World
Alamos Gold Inc. (TSE:AGI) Receives C$28.78 Average Target Price from Brokerages - Defense World
Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $3.90 Consensus Target Price from Analysts - Defense World
Spruce Biosciences Inc [SPRB] Investment Appeal on the Rise - Knox Daily
Spruce Biosciences Inc (NASDAQ: SPRB) Stock Has Gained 4.05% Over The Month – Is There Room For Growth? - Marketing Sentinel
Should You Expect Akero Therapeutics Inc (NASDAQ:AKRO) To Recover From Its 70.02% Gain From Highs? - Marketing Sentinel
Five Point Holdings LLC (NYSE: FPH): Can The Stock Still Lose Despite An 54.23% YTD Gain? - Marketing Sentinel
Why you might not want to use AI to spruce up your job application - Yahoo
Spruce Biosciences Inc (SPRB) Stock Price and Analyst Predictions - The News Heater
Spruce Biosciences Inc (NASDAQ:SPRB) stock: You might be surprised - US Post News
Examining OppFi Inc (OPFI) stock is warranted - US Post News
(PDF) Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials - ResearchGate
Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $3.90 Consensus Target Price from Brokerages - Defense World
스프루스 바이오 (SPRB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
스프루스 바이오 주식 (SPRB) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Charlton Ralph William III | CHIEF MEDICAL OFFICER |
Dec 10 '24 |
Option Exercise |
0.00 |
106,400 |
0 |
161,773 |
Gharib Samir M. | PRESIDENT AND CFO |
Dec 16 '24 |
Option Exercise |
0.00 |
75,750 |
0 |
363,841 |
Gharib Samir M. | PRESIDENT AND CFO |
Dec 10 '24 |
Option Exercise |
0.00 |
154,000 |
0 |
356,776 |
Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER |
Dec 16 '24 |
Option Exercise |
0.00 |
200,700 |
0 |
506,796 |
Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER |
Dec 10 '24 |
Option Exercise |
0.00 |
358,800 |
0 |
466,121 |
자본화:
|
볼륨(24시간):